In Vivo Imaging Today and Tomorrow: How multimodal imaging is driving translational research


It has been two decades since researchers at Stanford University showed that the progression of disease can be tracked non-invasively in living animals using bioluminescence imaging. Since then, researchers have developed and utilized a variety of molecular imaging technologies to increase our understanding of complex diseases and develop new therapeutic solutions. During this webinar, Dr. Chris Contag from Stanford University and Dr. Anna Moore from Harvard Medical School discussed the significant impact that imaging technologies have had on biomedicine and translational research, as well as bio-imaging's role in new and emerging scientific areas.